癌性胸腹水是恶性肿瘤晚期转移的常见并发症,仅靠抽水治疗无效,反而促使胸腹水生长迅速。回顾以往胸腹腔内注射抗癌药物如:5—Fu、MMC、CTX、HN_2等,虽有一定疗效,但对控制胸腹水的生长仍不能令人满意。近年应用顺珀药物,被认为是一种广谱抗癌药,并广泛用于全身治疗。我科自1985年3月开始用顺珀胸腹腔内注射治疗癌性胸腹水病人86例。临床取得满意疗效。现评价如下: Cancerous pleural effusion and ascites is a common complication of advanced metastasis of malignant tumors. It is not effective only by pumping, but it promotes rapid growth of pleural effusion. Recalling the previous intrathoracic and intra-abdominal injection of anti-cancer drugs such as 5-Fu, MMC, CTX, HN2, etc., although there is a certain effect, but the control of the growth of pleural effusion is still not satisfactory. Shunpo drug has been used in recent years and is considered to be a broad-spectrum anticancer drug and is widely used for systemic treatment. In our department since March 1985, it has been used in the treatment of 86 patients with cancerous pleural effusion and ascites. Get satisfactory clinical results. The evaluation is as follows: